Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond T Chung

Showing results (21-30 of 616) with videos related to

Pageof 62
Sort By:
Clinical and Translational Gastroenterology|September 16, 2016
Treatment of Hepatitis B: A Concise ReviewRuma Rajbhandari, Raymond T Chung
Clinical Pharmacology in Drug Development|March 7, 2017
Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug InteractionsJustin Chan, Raymond T Chung
Taehan Kan Hakhoe Chi = the Korean Journal of Hepatology|December 27, 2003
New antiviral therapies for hepatitis CJacqueline O'Leary, Raymond T Chung
Current Infectious Disease Reports|June 21, 2005
Update on Hepatitis B and C Coinfection in HIVPatrick Yachimski, Raymond T Chung
Hepatology (Baltimore, Md.)|March 7, 2008
Development of novel agents for the treatment of hepatitis C virusTracy Swan, Raymond T Chung
JAMA Internal Medicine|June 30, 2025
Study Limitations in Statin Use and Risk of Hepatocellular Carcinoma-ReplyJonggi Choi, Raymond T Chung
Alimentary Pharmacology & Therapeutics|July 6, 2026
Letter: HBsAg Loss After COVID-19 Vaccination: Implications for HBV Screening, Immunity Monitoring, and Health Worker Protection in LMICs. Authors' ReplyJonggi Choi, Raymond T Chung
Gastro Hep Advances|January 6, 2025
Association of Statin, Metformin, and Aspirin Use With Hepatocellular Carcinoma in the <i>All of Us</i> Research ProgramErik Almazan, Raymond T Chung
The AIDS Reader|October 30, 2004
Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remainPatrick Yachimski, Raymond T Chung
Clinical and Molecular Hepatology|January 9, 2026
Reaffirming the Role of SGLT2 Inhibitors in Slowing Fibrotic Progression in MASLDJonggi Choi, Raymond T Chung
Pageof 62

Showing results (21-30 of 616) with videos related to

Sort By:
Pageof 62
Clinical and Translational Gastroenterology|September 16, 2016
Treatment of Hepatitis B: A Concise ReviewRuma Rajbhandari, Raymond T Chung
Clinical Pharmacology in Drug Development|March 7, 2017
Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug InteractionsJustin Chan, Raymond T Chung
Taehan Kan Hakhoe Chi = the Korean Journal of Hepatology|December 27, 2003
New antiviral therapies for hepatitis CJacqueline O'Leary, Raymond T Chung
Current Infectious Disease Reports|June 21, 2005
Update on Hepatitis B and C Coinfection in HIVPatrick Yachimski, Raymond T Chung
Hepatology (Baltimore, Md.)|March 7, 2008
Development of novel agents for the treatment of hepatitis C virusTracy Swan, Raymond T Chung
JAMA Internal Medicine|June 30, 2025
Study Limitations in Statin Use and Risk of Hepatocellular Carcinoma-ReplyJonggi Choi, Raymond T Chung
Alimentary Pharmacology & Therapeutics|July 6, 2026
Letter: HBsAg Loss After COVID-19 Vaccination: Implications for HBV Screening, Immunity Monitoring, and Health Worker Protection in LMICs. Authors' ReplyJonggi Choi, Raymond T Chung
Gastro Hep Advances|January 6, 2025
Association of Statin, Metformin, and Aspirin Use With Hepatocellular Carcinoma in the <i>All of Us</i> Research ProgramErik Almazan, Raymond T Chung
The AIDS Reader|October 30, 2004
Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remainPatrick Yachimski, Raymond T Chung
Clinical and Molecular Hepatology|January 9, 2026
Reaffirming the Role of SGLT2 Inhibitors in Slowing Fibrotic Progression in MASLDJonggi Choi, Raymond T Chung
Pageof 62